[go: up one dir, main page]

MX2007003468A - Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas. - Google Patents

Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.

Info

Publication number
MX2007003468A
MX2007003468A MX2007003468A MX2007003468A MX2007003468A MX 2007003468 A MX2007003468 A MX 2007003468A MX 2007003468 A MX2007003468 A MX 2007003468A MX 2007003468 A MX2007003468 A MX 2007003468A MX 2007003468 A MX2007003468 A MX 2007003468A
Authority
MX
Mexico
Prior art keywords
methods
medicinal aerosol
aerosol formulations
synthesizing
ingredients therefor
Prior art date
Application number
MX2007003468A
Other languages
English (en)
Inventor
John T Capecchi
Kevin J Bechtold
Robert S Davidson
Sarah B Gunderson
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of MX2007003468A publication Critical patent/MX2007003468A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe un producto medicinal en aerosol y el proceso, tal como para un inhalador de dosis medida de HFA, en donde al menos uno de los ingredientes de la formulacion es utilizado al realizar al menos parte de la reaccion quimica para elaborar el ingrediente en un medio de reaccion de hidrofluoroalcano.
MX2007003468A 2004-09-24 2005-09-06 Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas. MX2007003468A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61306304P 2004-09-24 2004-09-24
PCT/US2005/031716 WO2006036473A1 (en) 2004-09-24 2005-09-06 Medicinal aerosol formulations and methods of synthesizing ingredients therefor

Publications (1)

Publication Number Publication Date
MX2007003468A true MX2007003468A (es) 2007-05-18

Family

ID=36119215

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003468A MX2007003468A (es) 2004-09-24 2005-09-06 Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.

Country Status (9)

Country Link
US (1) US20070286815A1 (es)
EP (1) EP1807122A4 (es)
JP (1) JP2008514600A (es)
CN (1) CN101027088A (es)
AU (1) AU2005290068A1 (es)
BR (1) BRPI0515891A (es)
CA (1) CA2581575A1 (es)
MX (1) MX2007003468A (es)
WO (1) WO2006036473A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2599464A1 (en) * 2005-03-14 2006-09-21 3M Innovative Properties Company Biocompatible polymer compounds for medicinal formulations
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
EP2773324A4 (en) * 2011-11-03 2015-07-01 Prec Dermatology Inc STABLE DERMATOLOGICAL AEROSOL FOAMS USING REACTIVE PROPELLERS
WO2015195711A2 (en) * 2014-06-16 2015-12-23 Shurtleff, James, Kevin Method and devices for manufacturing and delivering of aerosolized formulations
US9452178B1 (en) * 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328808D0 (en) * 1983-10-28 1983-11-30 Riker Laboratories Inc Inhalation responsive dispensers
US4819834A (en) * 1986-09-09 1989-04-11 Minnesota Mining And Manufacturing Company Apparatus and methods for delivering a predetermined amount of a pressurized fluid
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
EP0689424B1 (en) * 1993-03-17 1998-10-14 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
EP0708805B9 (en) * 1993-07-15 2012-03-21 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
US5478910A (en) * 1995-03-01 1995-12-26 Bayer Corporation Process for the production of polyesters using enzymes and supercritical fluids
AU698364B2 (en) * 1995-03-10 1998-10-29 Minnesota Mining And Manufacturing Company Aerosol valves
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
GB9718740D0 (en) * 1997-09-05 1997-11-12 Advanced Phytonics Ltd Improvements in or relating to the preparation of a compound
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6080899A (en) * 1999-01-25 2000-06-27 Alliedsignal Inc. Method of producing fluorinated organic compounds
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
TW503997U (en) * 2001-12-14 2002-09-21 Hon Hai Prec Ind Co Ltd Optical switch device
KR100503890B1 (ko) * 2002-10-08 2005-07-26 한국과학기술연구원 생분해성 폴리에스테르 중합체 및 압축기체를 이용한 이의제조방법
JP2007517032A (ja) * 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー 医薬組成物およびこれらの調製方法

Also Published As

Publication number Publication date
AU2005290068A1 (en) 2006-04-06
CA2581575A1 (en) 2006-04-06
EP1807122A1 (en) 2007-07-18
CN101027088A (zh) 2007-08-29
JP2008514600A (ja) 2008-05-08
BRPI0515891A (pt) 2008-08-12
US20070286815A1 (en) 2007-12-13
WO2006036473A1 (en) 2006-04-06
EP1807122A4 (en) 2009-04-22

Similar Documents

Publication Publication Date Title
UA89751C2 (ru) Состав, который содержит сульфат альбутерола и бромид ипратропия, способ его получения и ингалятор
WO2004037773A8 (en) Phenethanolamine derivative for the treatment of respiratory diseases
WO2003082853A8 (en) New compounds
AU2003244450A1 (en) Formulations for inhalation
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
BR0010456A (pt) Uso de xenÈnio para tratar neurointoxicações, preparação inalável e método para produzir uma preparação inalável
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
GB0323684D0 (en) Improvements in or relating to organic compounds
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
MXPA05008690A (es) Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
GB0016876D0 (en) Novel formulation
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
TW200505452A (en) Chemical compounds
WO2005097076A3 (en) Low dose pharmaceutical products
PT1583538E (pt) Utilização da 3-metoxi-pregnenolona para a preparação de um medicamento destinado a tratar as doenças neurodegenerativas
TW200716618A (en) Chemical compounds
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
MX2007003468A (es) Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MXPA04005552A (es) Analogos de vitamina d.
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей

Legal Events

Date Code Title Description
FA Abandonment or withdrawal